SNWV Stock Overview
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
SANUWAVE Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.022 |
| 52 Week High | US$0.03 |
| 52 Week Low | US$0.0046 |
| Beta | 1.01 |
| 1 Month Change | 10.00% |
| 3 Month Change | 7.32% |
| 1 Year Change | -12.00% |
| 3 Year Change | -85.46% |
| 5 Year Change | -87.29% |
| Change since IPO | -99.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| SNWV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -4.3% | 1.2% | 2.7% |
| 1Y | -12.0% | -0.05% | 26.0% |
Return vs Industry: SNWV underperformed the US Medical Equipment industry which returned -1.9% over the past year.
Return vs Market: SNWV underperformed the US Market which returned 25% over the past year.
Price Volatility
| SNWV volatility | |
|---|---|
| SNWV Average Weekly Movement | 14.0% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SNWV has not had significant price volatility in the past 3 months.
Volatility Over Time: SNWV's weekly volatility has decreased from 23% to 14% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 31 | Morgan Frank | sanuwave.com |
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company’s pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy.
SANUWAVE Health, Inc. Fundamentals Summary
| SNWV fundamental statistics | |
|---|---|
| Market cap | US$25.09m |
| Earnings (TTM) | -US$25.81m |
| Revenue (TTM) | US$20.40m |
1.2x
P/S Ratio-1.0x
P/E RatioIs SNWV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNWV income statement (TTM) | |
|---|---|
| Revenue | US$20.40m |
| Cost of Revenue | US$6.04m |
| Gross Profit | US$14.36m |
| Other Expenses | US$40.17m |
| Earnings | -US$25.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.023 |
| Gross Margin | 70.41% |
| Net Profit Margin | -126.52% |
| Debt/Equity Ratio | -72.8% |
How did SNWV perform over the long term?
See historical performance and comparison